Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
ETH shines with smart contracts and decentralized apps, while BTC remains a store of value and payments option. This overview highlights their use cases.
28,554 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Rivian shares surged about 8% after the company unveiled the R2 midsize SUV, signaling a push toward broader market a...
Moody’s Analytics now sees a near-even chance of a U.S. recession within the next year, as energy shocks and a coolin...
Memory chips are fueling a renewed AI stock rally, but Harvard’s Willy Shih cautions that the boom could cool. Here’s...
The market presses higher as investors cling to earnings resilience and policy stability, with AI and defense leading...
Investors are weighing whether to buy Nvidia stock before a key date. This practical guide lays out a framework, scen...
A sizable $12 million stake in a floor-and-decor retailer arrives as the stock trades off. This article breaks down t...
A new Grok AI forecast linked to Elon Musk projects XRP reaching up to $7 by late 2026. The forecast comes as ETFs, r...
A rare stock market signal has flashed again, marking the ninth occurrence since 1950. Goldman Sachs says the readout...
Gen Z is increasingly skipping the driver's license in favor of rideshare options from Uber and others. The trend cou...
UnitedHealth stock quietly soared about 80% off its 2025 low, signaling a meaningful rebound. This article dives into...
What if you could peek a decade ahead? Ford stock could be a compelling long-term bet if you understand the auto indu...